Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height
Phase 3
Completed
- Conditions
- Growth Disorder
- Registration Number
- NCT00174421
- Lead Sponsor
- Pfizer
- Brief Summary
This trial evaluates whether long-term treatment with Genotropin normalizes final (adult) height in short children born small for gestational age
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
- Participation in the 90-080 study
Exclusion Criteria
- Any severe, acute or chronic disease
- Any other identifiable reason for short stature
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Final height, compared to the expected familial target height
- Secondary Outcome Measures
Name Time Method Body weight, body mass index at final height; adverse events and assessment of hematological and clinical chemistry